Thursday, April 26, 2012
• Pacira Pharmaceuticals Inc., of Parsippany, N.J., said underwriters exercised in full their overallotment option for an additional 900,000 shares of common stock priced at $9.75 apiece, for proceeds of about $8.2 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.